Linkage studies in a Li-Fraumeni family with increased expression of p53 protein but no germline mutation in p53

British Journal of Cancer

Volumn 70, Issue 6, 1994, Pages 1176-1181

  Birch, J M ^a   Heighway, J ^b   Teare, M D ^a   Kelsey, A M ^c   Hartley, A L ^a   Tricker, K J ^a   Crowther, D ^b   Lane, D P ^d   Santibenez Koref M F ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b CHRISTIE HOSPITAL   (United Kingdom)

^c ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

^d UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; PROTEIN P53;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER SUSCEPTIBILITY; CHROMOSOME 12Q; CHROMOSOME 13Q; CHROMOSOME 17Q; CONTROLLED STUDY; DNA POLYMORPHISM; DNA SEQUENCE; FAMILIAL CANCER; FEMALE; GENE AMPLIFICATION; GENE LOCATION; GENE LOCUS; GENE MUTATION; GENETIC LINKAGE; HISTOGENESIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; ONCOGENE; PHENOTYPE; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN BINDING; SARCOMA;

BASE SEQUENCE; DNA PRIMERS; FEMALE; GENES, P53; GENETIC MARKERS; HUMAN; LI-FRAUMENI SYNDROME; LINKAGE (GENETICS); MALE; MOLECULAR SEQUENCE DATA; PEDIGREE; PROTEIN P53; PROTO-ONCOGENE PROTEINS; SUPPORT, NON-U.S. GOV'T;

EID: 0028172939     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1994.468     Document Type: Article

References (30)

1. ANDERSEN, T.I., HOLM, R., NESLAND, J.M., HEIMDAL, K.R., OTTESTAD, L. & BORRESEN, A.-L. (1993). Prognostic significance of TP53 alterations in breast carcinoma. Br. J. Cancer, 68. 540–548.
2. BARNES, D M., HANBY, A.M., GILLETT, C.E., MOHAMMED, S., HODGSON, S., BOBROW, L.G., LEIGH, I.M., PURKIS, T., MACGEOCH, C., SPURR, N.K., BARTEK, J., VOJTESEK, B., PICK-SLEY, S.M. & LANE, D.P. (1992). Abnormal expression of wild type p53 protein in normal cells of a cancer family patient Lancet, 340, 259–263.
3. BARTEK, J., BARTKOVA, J., VOJTESEK, B., STASKOVA, Z., LUKAS, J., REJTHAR, A., KOVARIK, J., MIDGLEY, C.A., GANNON, J.V. & LANE, D.P. (1991). Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies. Oncogene, 6, 1699–1703.
4. BIRCH, J.M., HARTLEY, A.L., BLAIR, V., KELSEY, A.M., HARRIS, M., TEARE, M.D. & MORRIS JONES, P.H. (1990). Cancer in the families of children with soft tissue sarcoma. Cancer, 66
5. BIRCH, J.M., HARTLEY, A.L., SANTIBÂNEZKOREF, M.F., TRICKER, K.J., PROSSER, J., CONDIE, A., KELSEY, A.M., HARRIS, M., MORRIS JONES, PH., BINCHY, A., CROWTHER, D., CRAFT, A.W., EDEN, O.B., EVANS, D.G.R., THOMPSON, E., MANN, J R. & MARTIN, J. (1994). Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Cancer Res., 54, 1298–1304.
6. BRUGIÈRES, L., GARDES, M., MOUTOU, C., CHOMPRET, A., MERESSE, V., MARTIN, A., POISSON, N., FLAMANT, F., BONAÏTI-PELLIÉ, C., LEMERLE, J. & FEUNTEUN, J. (1993). Screening for germ line p53 mutations in children with malignant tumors and a family history of cancer. Cancer Res., 53, 452–455.
7. DITTMER, D., PATI, S., ZAMBETTI, G., CHU, S., TERESKY, A.K., MOORE, M., FINLAY, C. & LEVINE, A.J. (1993). Gain of function mutations in p53. Nature Genet., 4, 42–45.
8. EASTON, D.F., BISHOP, D.T., FORD, D., CROCKFORD, G.P. AND THE BREAST CANCER LINKAGE CONSORTIUM (1993). Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. Am. J. Hum. Genet., 52, 678–701.
9. FUTREAL, P.A., BARRETT, J.C. & WISEMAN, R.W. (1991). An Alu polymorphism intragenic to the TP53 gene. Nucleic Acids Res., 19, 6977.
10. GARBER, J.E., GOLDSTEIN, A.M., KANTOR, A.F., DREYFUS, M.G., FRAUMENI, Jr, J.F. & LI, F.P. (1991). Follow-up study of twenty- four families with Li-Fraumeni syndrome. Cancer Res., 51, 6094–6097.
11. HARRIS, N., BRILL, E., SHOHAT, O., PROKOCIMER, M., WOLF, D., ARAI, N. & ROTTER, V. (1986). Molecular basis for heterogeneity of the human p53 protein. Mol. Cell. Biol., 6, 4650–4656.
12. HEIGHWAY, J., THATCHER, N., CERNY, T. & HASLETON, P.S. (1986). Genetic predisposition to human lung cancer. Br. J. Cancer, 53, 453–457.
13. HEIGHWAY, J., MITCHELL, E.L.D., JONES, D., WHITE, G.R.M. & SANTIBANEZ-KOREF, M.F. (1994). A transcribed polymorphism and sub-localisation of MDM2. Hum. Genet., 93, 611–612.
14. JONES, M.H. & NAKAMURA, Y. (1992). Detection of loss of constitutional heterozygosity at the human TP53 locus using a dinucleotide repeat. Genes Chrom. Cancer, 5, 89–90.
15. KONDOLEON, S., VISSING, H., LUO, X.Y., KELLOG, J. & LITT, M. (1987). A hypervariable RFLP on chromosome 17pl3 is defined by an arbitrary single copy probe pl44-D6. Nucleic Acids Res., 15, 10605.
16. LANE, D P. & BENCHIMOL, S. (1990). p53: oncogene or antioncogene? Genes Dev., 4, 1–8.
17. LAW, J.C., STRONG, L.C., CHIDAMBARAM, A. & FERRELL, R.E. (1991). A germ line mutation in exon 5 of the p53 gene in an extended cancer family. Cancer Res., 51, 6385–6387.
18. LEACH, F.S., TOKINO, T., MELTZER, P., BURRELL, M., OLINER, J.D., SMITH, S., HILL, D.E., SIDRANSKY, D., KINZLER, K.W. & VOGELSTEIN, B. (1993). p53 mutation and MDM2 amplification in human soft tissue sarcomas. Cancer Res., 53, 2231–2234.
19. LUSTBADER, E.D., WILLIAMS, W.R., BONDY, M L., STROM, S. & STRONG, L.C. (1992). Segregation analysis of cancer in families of childhood soft-tissue-sarcoma patients. Am. J. Hum. Genet., 51, 344–356.
20. MCGEE, T.L., COWLEY, G.S., YANDELL, D.W. & DRYJA, T.R. (1990). Detection of the Xbal RFLP within the retinoblastoma locus by PCR. Nucleic Acids Res., 18, 207.
21. MALKIN, D., LI, F.P., STRONG, L.C., FRAUMENI, Jr, J.F., NELSON, C.E., KIM, D.H., KASSEL, J., GRYKA, M.A., BISCHOFF, F.Z., TAINSKY, M.A. & FRIEND, S.H. (1990). Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science, 250, 1233–1338.
22. MIDGLEY, C.A., FISHER, C.J., BARTEK, J., VOJTESEK, B., LANE, D P. & BARNES, D M. (1992). Analysis of p53 expression in human tumours: an antibody raised against human p53 expressed in E. coli. J. Cell Sci., 101, 183–189.
23. MOMAND, J., ZAMBETTI, G.P., OLSON, D C., GEORGE, D. & LEVINE, A.J. (1992). The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell, 69, 1237–1245.
24. OLINER, J.D., KINZLER, K.W., MELTZER, P.S., GEORGE, D.L. & VOGELSTEIN, B. (1992). Amplification of a gene encoding a p53-associated protein in human sarcoma. Nature, 358, 80–83.
25. REIFENBERGER, G., LIU, L., ICHIMURA, K., SCHMIDT, E.E. & COLLINS, V.P. (1993). Amplification and overexpression of the (iMDM2) gene in a subset of human malignant gliomas without (ip53) mutations. Cancer Res., 53, 2736–2739.
26. SANTIBANEZ-KOREF, M.F., BIRCH, J.M., HARTLEY, A.L., MORRIS JONES, P H., CRAFT, A.W., EDEN, T., CROWTHER, D., KELSEY, A.M. & HARRIS, M. (1991). p53 germline mutations in Li-Fraumeni syndrome. Lancet, 338, 1490–1491.
27. SRIVASTAVA, S., ZOU, Z., PIROLLO, K., BLATTNER, W. & CHANG, E.H. (1990). Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature, 348, 747–749.
28. STRATTON, M R., WILLIAMS, S., FISHER, C., BALL, A., WESTBURY, G., GUSTERSON, B.A., FLETCHER, C.D.M., KNIGHT, J.C., FUNG, Y.-K., REEVES, B.R. & COOPER, C.S. (1989). Structural alterations of the RBI gene in human soft tissue tumours. Br. J. Cancer, 60, 202–205.
29. TEARE, M.D., SANTIBANEZ-KOREF, M.F., WALLACE, S.A., WHITE, G.R.M., EVANS, D.G.R., BURNELL, L.D., HARRIS, M., HOWELL, A. & BIRCH, J.M. (1993). A linkage study in seven breast cancer families. Am. J. Hum. Genet., 52, 786–788.
30. TOGUCHIDA, J., YAMAGUCHI, T., DAYTON, S.H., BEAUCHAMP, R.L., HERRERA, G.E., ISHIZAKI, K., KAMAMURO, T., MAYERS, PA., LITTLE, J.B., SASAKI, M.A., WEICHSELBAUM, R.R. & YANDELL, D.W. (1992). Prevalence and spectrum of germline mutations of the p53 gene among patients with sarcoma. N. Engl. J. Med., 326, 1301–1308.